[1] 于文雪, 孙禹欣, 金莉莉, 等.NAFLD的发病机制与新型治疗药物研发[J].中国细胞生物学学报, 2020, 42(3): 499-506.DOI: 10.11844/cjcb.2020.03.0016. [2] 冯秋琪, 任国艳, 乔香君, 等.脂肪肝细胞模型的研究进展[J].中国细胞生物学学报, 2020, 42(12): 2256-2265. [3] CARR R M, ORANU A, KHUNGAR V.Nonalcoholic fatty liver disease: pathophysiology and management[J].Gastroenterol Clin North Am, 2016, 45(4): 639-652.DOI: 10.1016/j.gtc.2016.07.003. [4] FAN J G, KIM S U, WONG V W.New trends on obesity and NAFLD in Asia[J].J Hepatol, 2017, 67(4): 862-873.DOI: 10.1016/j.jhep.2017.06.003. [5] LI J, ZOU B Y, YEO Y H, et al.Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis[J].Lancet Gastroenterol Hepatol, 2019, 4(5): 389-398.DOI: 10.1016/S2468-1253(19)30039-1. [6] ZHOU F, ZHOU J, WANG W, et al.Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and Meta-analysis[J].Hepatology, 2019, 70(4): 1119-1133.DOI: 10.1002/hep.30702. [7] 黄海燕, 辛永宁, 姜曼, 等.非酒精性脂肪性肝病动物实验模型研究进展[J].临床肝胆病杂志, 2014, 30(9): 948-953.DOI: 10.3969/j.issn.1001-5256.2014.09.028. [8] LAU J K, ZHANG X, YU J.Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances[J].J Pathol, 2017, 241(1): 36-44.DOI: 10.1002/path.4829. [9] FEBBRAIO M A, REIBE S, SHALAPOUR S, et al.Preclinical models for studying NASH-driven HCC: how useful are they?[J].Cell Metab, 2019, 29(1): 18-26.DOI: 10.1016/j.cmet.2018.10.012. [10] 李妍, 蔡晓波, 陆伦根.脂肪性肝病动物模型研究进展[J].国际消化病杂志, 2019, 39(3): 157-161.DOI: 10.3969/j.issn.1673-534X.2019.03.004. [11] 刘楠楠, 李虎, 彭宗根.肝脂肪变性细胞实验模型与机制研究进展[J].国际药学研究杂志, 2019, 46(3): 171-175.DOI: 10.13220/j.cnki.jipr.2019.03.002. [12] HE Y, YANG W H, GAN L L, et al.Silencing HIF-1α aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-α/ANGPTL4 singling pathway[J].Gastroenterol Hepatol, 2020: S0210-5705(20)30395-2.DOI: 10.1016/j.gastrohep.2020.09.014. [13] GÓMEZ-LECHÓN M J, DONATO M T, MARTÍNEZ-ROMERO A, et al.A human hepatocellular in vitro model to investigate steatosis[J].Chem Biol Interact, 2007, 165(2): 106-116.DOI: 10.1016/j.cbi.2006.11.004. [14] HARRIS A J, DIAL S L, CASCIANO D A.Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells[J].Mutat Res, 2004, 549(1/2): 79-99.DOI: 10.1016/j.mrfmmm.2003.11.014. [15] MATHIJS K, KIENHUIS A S, BRAUERS K J, et al.Assessing the metabolic competence of sandwich-cultured mouse primary hepatocytes[J].Drug Metab Dispos, 2009, 37(6): 1305-1311.DOI: 10.1124/dmd.108.025775. [16] COULON S, LEGRY V, HEINDRYCKX F, et al.Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models[J].Hepatology, 2013, 57(5): 1793-1805.DOI: 10.1002/hep.26219. [17] YIN Z H, ELLIS E C, NOWAK G.Isolation of mouse hepatocytes for transplantation: a comparison between antegrade and retrograde liver perfusion[J].Cell Transplant, 2007, 16(8): 859-865.DOI: 10.3727/000000007783465235. [18] 陈阳洁, 高柯欣, 王智豪, 等.小鼠肝实质细胞的分离、鉴定及原代培养[J].畜牧与饲料科学, 2019, 40(4): 7-11.DOI: 10.16003/j.cnki.issn1672-5190.2019.04.002. [19] SCHAART G, HESSELINK R P, KEIZER H A, et al.A modified PAS stain combined with immunofluorescence for quantitative analyses of glycogen in muscle sections[J].Histochem Cell Biol, 2004, 122(2): 161-169.DOI: 10.1007/s00418-004-0690-0. [20] WU J, MENG Z J, JIANG M, et al.Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells[J].Hepatology, 2009, 49(4): 1132-1140.DOI: 10.1002/hep.22751. [21] 晏贤春, 胡彬, 王赫, 等.游离脂肪酸诱导小鼠肝实质细胞体外脂肪化并加速细胞凋亡[J].肝脏, 2013, 18(5): 306-309.DOI: 10.3969/j.issn.1008-1704.2013.05.007. [22] SHIN S K, CHO H W, SONG S E, et al.Catalase and nonalcoholic fatty liver disease[J].Pflugers Arch-Eur J Physiol, 2018, 470(12): 1721-1737.DOI: 10.1007/s00424-018-2195-z. [23] STEFAN N, HÄRING H U, CUSI K.Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies[J].Lancet Diabetes Endocrinol, 2019, 7(4): 313-324.DOI: 10.1016/S2213-8587(18)30154-2. [24] GREEN C J, PRAMFALK C, MORTEN K J, et al.From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations[J].Am J Physiol Endocrinol Metab, 2015, 308(1): E1-E20.DOI: 10.1152/ajpendo.00192.2014. [25] 周萍, 樊静, 梁韡.一种简易小鼠原代肝细胞分离方法[J].成都大学学报(自然科学版), 2016, 35(4): 328-330.DOI: 10.3969/j.issn.1004-5422.2016.04.004. [26] 吕建军, 李耀庭, 周舒雅, 等.建立原代小鼠肝细胞体外模型用于致癌物作用机制研究[J].药物分析杂志, 2016, 36(10): 1785-1797.DOI: 10.16155/j.0254-1793.2016.10.12. |